Filed: 2/13/2024ACC: 0001420506-24-000248
📋 What this filing means
STEMPOINT CAPITAL LP filed this quarterly 13F‑HR report disclosing 63 equity positions with a total reported market value of $374.83M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
63
Positions
$374.83M
Total AUM (reported)
27.73M
Total Shares
Allocation by class
COM$248.71M66.4%
SHS$37.27M9.9%
CALL$23.07M6.2%
COMMON STOCK$17.69M4.7%
COM NEW$12.38M3.3%
CLASS A ORD$10.47M2.8%
SPONSORED ADS$6.30M1.7%
Portfolio Concentration
Top 3$65.70M17.5%
4–10$82.85M22.1%
11–25$122.59M32.7%
Rest$103.69M27.7%
Top 3 weight
17.5%
Top 10 weight
39.6%
Voting Authority Distribution
Total shares with voting rights: 27.73M
Sole
Full voting authority
23.11M
shares
% of voting shares83.3%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
4.62M
shares
% of voting shares16.7%
Investment Discretion (by position count)
Sole63
Shared0
Other0
Dominant voting typeSole · 83.3% of voting shares
Institutional Holdings63
Rows:
ROIVANT SCIENCES LTD
SOLEShares2.17M
TypeSH
Market value$24.36M
6.50%
Sole
1.87M
Shared
0.00
None
302.83K
SYNDAX PHARMACEUTICALS INC
SOLEShares1.09M
TypeSH
Market value$23.65M
6.31%
Sole
985.05K
Shared
0.00
None
109.44K
ARCELLX INC
SOLEShares314.23K
TypeSH
Market value$17.69M
4.72%
Sole
282.69K
Shared
0.00
None
31.54K
MERUS N V
SOLEShares501.81K
TypeSH
Market value$13.80M
3.68%
Sole
413.86K
Shared
0.00
None
87.94K
IMMUNOVANT INC
SOLEShares322.01K
TypeSH
Market value$13.57M
3.62%
Sole
263.60K
Shared
0.00
None
58.41K
AMICUS THERAPEUTICS INC
SOLEShares862.82K
TypeSH
Market value$12.24M
3.27%
Sole
862.82K
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares513.68K
TypeSH
Market value$11.78M
3.14%
Sole
513.68K
Shared
0.00
None
0.00
IMMATICS N.V
SOLEShares1.02M
TypeSH
Market value$10.74M
2.87%
Sole
780.58K
Shared
0.00
None
239.63K
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares168.35K
TypeSH
Market value$10.47M
2.79%
Sole
168.35K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares253.95K
TypeSH
Market value$10.25M
2.74%
Sole
253.95K
Shared
0.00
None
0.00
CABALETTA BIO INC
SOLEShares450.71K
TypeSH
Market value$10.23M
2.73%
Sole
302.81K
Shared
0.00
None
147.89K
ARGENX SE
SOLEShares26.48K
TypeSH
Market value$10.08M
2.69%
Sole
26.48K
Shared
0.00
None
0.00
MERCK & CO INC
SOLEShares89.02K
TypeSH
Market value$9.70M
2.59%
Sole
89.02K
Shared
0.00
None
0.00
JOHNSON & JOHNSON
SOLEShares61.01K
TypeSH
Market value$9.56M
2.55%
Sole
61.01K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares249.57K
TypeSH
Market value$8.88M
2.37%
Sole
209.24K
Shared
0.00
None
40.34K
ELI LILLY & CO
SOLEShares15.07K
TypeSH
Market value$8.78M
2.34%
Sole
15.07K
Shared
0.00
None
0.00
VISTAGEN THERAPEUTICS INC
SOLEShares1.79M
TypeSH
Market value$8.76M
2.34%
Sole
1.59M
Shared
0.00
None
196.75K
ARCUTIS BIOTHERAPEUTICS INC
SOLEShares2.59M
TypeSH
Market value$8.38M
2.24%
Sole
2.06M
Shared
0.00
None
534.92K
SPYRE THERAPEUTICS INC
SOLEShares378.77K
TypeSH
Market value$8.15M
2.17%
Sole
313.38K
Shared
0.00
None
65.39K
DISC MEDICINE INC
SOLEShares126.43K
TypeSH
Market value$7.62M
2.03%
Sole
107.20K
Shared
0.00
None
19.23K
TEVA PHARMACEUTICAL INDS LTD
SOLEShares701.60K
TypeSH
Market value$7.32M
1.95%
Sole
701.60K
Shared
0.00
None
0.00
LANTHEUS HLDGS INC
SOLEShares108.91K
TypeSH
Market value$6.75M
1.80%
Sole
108.91K
Shared
0.00
None
0.00
LEGEND BIOTECH CORP
SOLEShares104.65K
TypeSH
Market value$6.30M
1.68%
Sole
104.65K
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares856.95K
TypeSH
Market value$6.16M
1.64%
Sole
601.44K
Shared
0.00
None
255.51K
SPDR S&P 500 ETF TR
SOLEShares16.42K
TypeSH
Market value$5.90M
1.58%
Sole
16.42K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ROIVANT SCIENCES LTDSOLE | SHS | 2.17M | SH | $24.36M 6.50% | 1.87M | 0.00 | 302.83K |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 1.09M | SH | $23.65M 6.31% | 985.05K | 0.00 | 109.44K |
ARCELLX INCSOLE | COMMON STOCK | 314.23K | SH | $17.69M 4.72% | 282.69K | 0.00 | 31.54K |
MERUS N VSOLE | COM | 501.81K | SH | $13.80M 3.68% | 413.86K | 0.00 | 87.94K |
IMMUNOVANT INCSOLE | COM | 322.01K | SH | $13.57M 3.62% | 263.60K | 0.00 | 58.41K |
AMICUS THERAPEUTICS INCSOLE | COM | 862.82K | SH | $12.24M 3.27% | 862.82K | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 513.68K | SH | $11.78M 3.14% | 513.68K | 0.00 | 0.00 |
IMMATICS N.VSOLE | SHS | 1.02M | SH | $10.74M 2.87% | 780.58K | 0.00 | 239.63K |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 168.35K | SH | $10.47M 2.79% | 168.35K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 253.95K | SH | $10.25M 2.74% | 253.95K | 0.00 | 0.00 |
CABALETTA BIO INCSOLE | COM | 450.71K | SH | $10.23M 2.73% | 302.81K | 0.00 | 147.89K |
ARGENX SESOLE | CALL | 26.48K | SH | $10.08M 2.69% | 26.48K | 0.00 | 0.00 |
MERCK & CO INCSOLE | COM | 89.02K | SH | $9.70M 2.59% | 89.02K | 0.00 | 0.00 |
JOHNSON & JOHNSONSOLE | COM | 61.01K | SH | $9.56M 2.55% | 61.01K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 249.57K | SH | $8.88M 2.37% | 209.24K | 0.00 | 40.34K |
ELI LILLY & COSOLE | COM | 15.07K | SH | $8.78M 2.34% | 15.07K | 0.00 | 0.00 |
VISTAGEN THERAPEUTICS INCSOLE | COM | 1.79M | SH | $8.76M 2.34% | 1.59M | 0.00 | 196.75K |
ARCUTIS BIOTHERAPEUTICS INCSOLE | COM | 2.59M | SH | $8.38M 2.24% | 2.06M | 0.00 | 534.92K |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 378.77K | SH | $8.15M 2.17% | 313.38K | 0.00 | 65.39K |
DISC MEDICINE INCSOLE | COM | 126.43K | SH | $7.62M 2.03% | 107.20K | 0.00 | 19.23K |
TEVA PHARMACEUTICAL INDS LTDSOLE | CALL | 701.60K | SH | $7.32M 1.95% | 701.60K | 0.00 | 0.00 |
LANTHEUS HLDGS INCSOLE | COM | 108.91K | SH | $6.75M 1.80% | 108.91K | 0.00 | 0.00 |
LEGEND BIOTECH CORPSOLE | SPONSORED ADS | 104.65K | SH | $6.30M 1.68% | 104.65K | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 856.95K | SH | $6.16M 1.64% | 601.44K | 0.00 | 255.51K |
SPDR S&P 500 ETF TRSOLE | TR UNIT | 16.42K | SH | $5.90M 1.58% | 16.42K | 0.00 | 0.00 |
Page 1 of 3